10 Apr 2017
(MENAFN) Egypt should enhance its collaboration in pharmaceutical sector with India, which has great advantages in terms of offering affordable and reliable medication.
Accordingly, Egypt is a huge market in which India sees growing export potentials as well as possibilities of investments, while it aims that the market will offer India the base to increase to other parts of the region.
Additionally, India formulation is backed by globally acceptable certification and updated by increasing R&D facilities.
India’s exports of pharmaceuticals in 2015/16 reached USD16.86bn, while Indian pharmaceutical industry with several thousand producers, export the largest share of generics to the world.
MENAFN1004201700450000ID1095382304
MENAFN1004201700450000ID1095382304
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
26 Jan 2026
BBK Enhances Autumn Fair 2026 Experience with Customized Rewards and Premium Services
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more